{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:58:10Z","timestamp":1761544690463,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.japh.2023.03.010","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:58:50Z","timestamp":1680523130000},"page":"1026-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Institutional policy consideration for medical cannabis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2159-5571","authenticated-orcid":false,"given":"Melani","family":"Kane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Vellky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simi","family":"Burn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-7079","authenticated-orcid":false,"given":"Denise M.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2023.03.010_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jamainternmed.2019.7517","article-title":"Trends in cannabis use among older adults in the United States, 2015\u20132018","volume":"180","author":"Han","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.japh.2023.03.010_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/can.2020.0064","article-title":"Patterns of medical cannabis use among older adults from a cannabis dispensary in New York State","volume":"7","author":"Kaufmann","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"issue":"3","key":"10.1016\/j.japh.2023.03.010_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1310\/hpj4903-215","article-title":"Transition of care: pharmacist help needed","volume":"49","author":"Kristeller","year":"2014","journal-title":"Hosp Pharm"},{"issue":"2","key":"10.1016\/j.japh.2023.03.010_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1310\/hpj5202-89","article-title":"Considerations for hospital policies regarding medical cannabis use","volume":"52","author":"Borgelt","year":"2017","journal-title":"Hosp Pharm"},{"author":"Cole","key":"10.1016\/j.japh.2023.03.010_bib8"},{"year":"2017","key":"10.1016\/j.japh.2023.03.010_bib9"},{"author":"Legislative Information","key":"10.1016\/j.japh.2023.03.010_bib10"},{"key":"10.1016\/j.japh.2023.03.010_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106798","article-title":"Cannabis use assessment and documentation in healthcare: priorities for closing the gap","volume":"153","author":"Sajdeya","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.japh.2023.03.010_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.09.005","article-title":"DSM-5 cannabis withdrawal syndrome: demographic and clinical correlates in U.S. adults","volume":"195","author":"Livne","year":"2019","journal-title":"Drug Alcohol Depend"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912300078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912300078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:16Z","timestamp":1761544336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912300078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S154431912300078X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.03.010","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Institutional policy consideration for medical cannabis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}